Actionable news
All posts from Actionable news
Actionable news in VKTX: Viking Therapeutics,

Analyst Says Viking Therapeutics Can Quadruple Because Of Its Relationship With Ligand Scientists

Trade with confidence. Are you a professional trader? Be the first to get the alert with Benzinga Pro's real-time newsfeed and audio squawk and never miss an opportunity again.
Don't miss the chance to try it FREE today.

The clinical-stage biopharmaceutical company was incorporated in 2012, and went public in 2015. At just shy of a year old, the metabolic/endocrine solutions company has seen some challenges, and is down 70 percent from its IPO price. However, analysts at H.C. Wainwright & Co. believe the company's luck may be changing.

Based upon Viking's relationship with Ligand Pharmaceuticals Inc. a>